Design, synthesis and biological evaluation of benzyl 2-(1H-imidazole-1-yl) pyrimidine analogues as selective and potent Raf inhibitors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Minjung | - |
dc.contributor.author | Lee, Junghun | - |
dc.contributor.author | Jung, Kyungjin | - |
dc.contributor.author | Kim, Hyangmi | - |
dc.contributor.author | Aman, Wagar | - |
dc.contributor.author | Ryu, Jae-Sang | - |
dc.contributor.author | Hah, Jung-Mi | - |
dc.date.accessioned | 2021-06-22T22:45:42Z | - |
dc.date.available | 2021-06-22T22:45:42Z | - |
dc.date.created | 2021-01-21 | - |
dc.date.issued | 2014-08 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/22030 | - |
dc.description.abstract | The synthesis of a novel series of (4-aminobenzyl/benzoyl)-1H-imidazol-1-yl pyrimidin-2-yl derivatives 9, 10, 18, 19 and their in vitro antiproliferative activities against the A375P human melanoma cell line and the U937 human leukemic monocyte lymphoma cell line are described. Potent antiproliferative effects were found from 91, 9s and 10c; 10c was found to be a highly potent and selective BRAF V600E and CRAF inhibitor (IC50 = 38.3 nM and 8.79 nM). (C) 2014 Elsevier Ltd. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.title | Design, synthesis and biological evaluation of benzyl 2-(1H-imidazole-1-yl) pyrimidine analogues as selective and potent Raf inhibitors | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Hah, Jung-Mi | - |
dc.identifier.doi | 10.1016/j.bmcl.2014.05.030 | - |
dc.identifier.scopusid | 2-s2.0-84904054114 | - |
dc.identifier.wosid | 000339228700080 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.24, no.15, pp.3600 - 3604 | - |
dc.relation.isPartOf | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 24 | - |
dc.citation.number | 15 | - |
dc.citation.startPage | 3600 | - |
dc.citation.endPage | 3604 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | MUTATIONS | - |
dc.subject.keywordPlus | MELANOMA | - |
dc.subject.keywordPlus | KINASE | - |
dc.subject.keywordPlus | BRAF | - |
dc.subject.keywordAuthor | (4-Aminobenzyl)-1H-imidazol-1-yl pyrimidin-2-yl derivatives | - |
dc.subject.keywordAuthor | Antiproliferative activity | - |
dc.subject.keywordAuthor | Melanoma | - |
dc.subject.keywordAuthor | BRAF V600E | - |
dc.subject.keywordAuthor | CRAF | - |
dc.subject.keywordAuthor | Selectivity | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0960894X14005307?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.